Adverse Effects of Not Knowing the OASIS-E Medication Items
The work we do at the beginning of care on medications has proven to be instrumental to the patient’s safety, controlling emergency department use, and hospitalization. Best practices have been built into the OASIS items for identifying drugs in high-risk drug classes, determining if physician/practitioner intervention is required, and prioritizing education on high-risk drugs. However, does your staff understand the subtleties of the guidance and best practices?
M2020 Oral Medication Management is one of the several quality measures used for both Star ratings and Value-Based Purchasing (VBP) outcomes. It is critical to implement these processes and respond to the items appropriately to ensure best outcomes. In this two-part master class series, our McBee experts will take a deep dive into the individual items covering best practices, tips and tricks, and the latest guidance.
Identify best practices with OASIS-E to optimize medication reconciliation.
Explain how OASIS-E medication items impact outcomes relating to acute care hospitalization.
Identify best practices to improve the Star ratings and Value-based purchasing M2020 Oral Medication Management outcome.
- Lisa Selman-HolmanVice President, Education & Quality, McBee
- Michelle HornerManager, Post-Acute Education, McBee